In our March issue of Pharmaceutical Executive
FEATURES
Cover Story
Living the Mission: Amicus Therapeutics' John Crowley
Lisa Henderson
Amicus Therapeutics CEO John Crowley, whose biotech journey and quest to cure two of his kids of a rare genetic disease is well chronicled, discusses the growing role of the patient-centered view in company culture—not just in adding "deeper meaning" to drug development, but in building patient advocacy into everyday business practice and strategy.
Download the digital issue
|
| |
 |
| |
Patient Focus
Patient Advocacy: The Corporate Mindset
Julian Upton
Perspectives from big pharma and the rare disease space on how patient advocacy is evolving as a corporate function.
Download the digital issue |
ADVERTISEMENT
Patient Adherence: A Hard Pill to Swallow?
Asia-Pacific: Thursday, April 11, 2019 at 11:30am IST | 2pm CST | 3pm JST
North America: Thursday, April 11, 2019 at 1pm EDT | 12pm CDT | 10am PDT
 Register Now |
Patient Focus
Research Bonds Strengthen
Michelle Maskaly
Efforts to collaborate around patient engagement in every phase of product development are illustrating the growing relationship between disease advocacy groups and industry.
Download the digital issue |
ADVERTISEMENT
Using Real-World Evidence for U.S. Regulatory Decision-Making: What Pharma Needs to Know
Wednesday, March 20, 2019 at 1pm EDT | 12pm CDT | 10am PDT
 Register Now |
Patient Focus
The Path to Patient-Focused Accountability
John Elliott
Benchmark survey assesses the industry's progress so far in moving from words to action in its approach to patient centricity.
Download the digital issue |
ADVERTISEMENT
Japan Market Entry: How to Navigate the Clinical Development Regulatory Environment and Best Methods to Utilize Opportunities
Tuesday, March 19, 2019 at 6pm EDT
 Register Now |
Roundtable
Pinpointing Performance of Key Access Activities
BCG Market Access Roundtable Working Group
An industry working group has developed a common framework focused on the most relevant access performance metrics (APMs).
Download the digital issue |
ALSO IN THIS ISSUE
What Does Patient Centricity Look Like?
Lisa Henderson
That often muddled picture is becoming increasingly clearer in the patient and business context as different ways in which patients, patient communities, advocacy, and pharma engage each other converge …Read more
Multiple Pharma Issues Top Congressional Agenda
Jill Wechsler
Wide-ranging probes to target marketing, pricing, and access …Read more
Pharm Exec Joins MJH Portfolio
Michael J. Hennessy Jr., president of MJH Associates‚ Inc., answers questions about the acquisition of UBM Life Sciences media brands and his company's perspective on the evolving biopharma landscape …Read more
|
| |
| WEBCASTS |
| Patient Adherence: A Hard Pill to Swallow? |
| Using Real-World Evidence for U.S. Regulatory Decision-Making: What Pharma Needs to Know |
Japan Market Entry: How to Navigate the Clinical Development Regulatory Environment and Best Methods to Utilize Opportunities
|
Patient Assistance Centers of Excellence: The Next Generation of Brand Support
|
Bringing Intelligence to Drug Discovery—The Importance of Contextual Information at All Levels
|
Seizing Opportunities in Japan, the Second Largest Innovation-Driven Pharmaceutical Market
|
Commercializing on Your Own: A Panel Discussion with Insights from Emerging Biopharma Executives
|
